GGrantIndex
← Leaderboards

Laura Margaret Sanchez

University Of California Santa Cruz

$2,229,601
Attributed
$4,574,111
Total exposure
3
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $890K · FY201824
$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$4,574,111 · 3

By mechanism

R01$4,144,119 · 2
R21$429,992 · 1

Top collaborators

Most similar at University Of California Santa Cruz

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Innovation

Research focus

InnovationProductionProteinsSmall MoleculeDetectionChemistrySamplingBiologicalSourceSeriesMass Spectrum AnalysisReporterChromatographyResearch PersonnelTechnologyLibrariesCellsConsumptionSiteBaseCoupledMass Spectrometric ImagingMicrobialLaboratories

Grant awards (19)

Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$371,644
R01 · FY2024 · CA
Development of a high throughput platform for screening directed evolution libraries$135,382
R21 · FY2024 · GM · contact PI
Development of a high throughput platform for screening directed evolution libraries$65,926
R21 · FY2024 · GM · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$40,632
R01 · FY2024 · CA
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$383,381
R01 · FY2023 · CA
Development of a high throughput platform for screening directed evolution libraries$162,758
R21 · FY2023 · GM · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$79,176
R01 · FY2023 · CA
Application of a high throughput platform for screening directed evolution libraries$65,926
R21 · FY2023 · GM · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$360,469
R01 · FY2022 · CA
Development of quantitative mass spectrometry assays and imaging for cancer metastasis$85,846
R01 · FY2022 · CA
A new paradigm for the creation and mining of microbial libraries for drug discovery$434,968
R01 · FY2021 · GM
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$376,650
R01 · FY2021 · CA
A new paradigm for the creation and mining of microbial libraries for drug discovery$504,305
R01 · FY2020 · GM
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$376,650
R01 · FY2020 · CA
A new paradigm for the creation and mining of microbial libraries for drug discovery$9,060
R01 · FY2020 · GM
A new paradigm for the creation and mining of microbial libraries for drug discovery$437,498
R01 · FY2019 · GM
A new paradigm for the creation and mining of microbial libraries for drug discovery (Equipment)$182,367
R01 · FY2019 · GM
MALDI-TOF MS/IDBac to discover antibiotics from the Great Lakes sponge microbiome$65,576
R01 · FY2019 · GM
A new paradigm for the creation and mining of microbial libraries for drug discovery$435,897
R01 · FY2018 · GM